Published: 2024-03-01
Original Articles
RNF135 promotes cell proliferation and autophagy in lung adenocarcinoma by promoting the phosphorylation of ULK1
Abstract 1079 | PDF Downloads 1392 HTML Downloads 0 XML Downloads 24Page 3-9
Safety of direct oral provocation test to delabel reported mild beta-lactam allergy in infants
Abstract 1098 | PDF Downloads 1133 HTML Downloads 0 XML Downloads 18Page 10-15
Isoegomaketone alleviates inflammatory response and oxidative stress in sepsis lung injury
Abstract 1185 | PDF Downloads 1385 HTML Downloads 0 XML Downloads 29Page 16-22
Association of behaviors and asthma control in a sample of Lebanese adolescents with asthma
Abstract 1253 | PDF Downloads 1298 HTML Downloads 0 XML Downloads 21Page 51-59
YBX-1 alleviates sepsis-stimulated lung epithelial cell injury
Abstract 1256 | PDF Downloads 1336 HTML Downloads 0 XML Downloads 15Page 60-67
Research Article
Are the presence of asthma and the COVID-19 infection associated with behavioral changes in Lebanese adolescents?
Abstract 907 | PDF Downloads 990 HTML Downloads 0 XML Downloads 20Page 68-79
Letter to Editor
Allergic rhinitis: therapeutic strategies update Lactococcus lactis Plasma and tranilast–roxithromycin combination
Abstract 1079 | PDF Downloads 917 HTML Downloads 0 XML Downloads 16Page 1-2
Review Article
Primary, secondary and tertiary prevention of food allergy: current practices and future directions
Abstract 2518 | PDF Downloads 2204 HTML Downloads 0 XML Downloads 202Page 32-44
Case Report
Omalizumab in the treatment of Morbihan syndrome in an adolescent girl – case report and literature review
Abstract 1684 | PDF Downloads 1794 HTML Downloads 0 XML Downloads 105Page 23-31
Cold-induced anaphylaxis triggered by drinking cold water
Abstract 2875 | PDF Downloads 1411 HTML Downloads 0 XML Downloads 488Page 45-47
Allergy to Gibberellin-regulated proteins in an adolescent: A case of orange-induced anaphylaxis mediated by cofactors
Abstract 822 | PDF Downloads 878 HTML Downloads 0 XML Downloads 36Page 48-50
Research Letter
Real-life experience after 3 months with tezepelumab before marketing approval
Abstract 1283 | PDF Downloads 1335 HTML Downloads 0 XML Downloads 84Page 80-82